11 October 2018
Virtus Health present further evidence to support AI technology in embryo selection
New data has been presented on the predictive value of the new artificial intelligence tool, Ivy. Ivy has, through analysis of time lapse images of IVF embryos, been shown to predict which embryos have the highest likelihood of leading to a viable pregnancy.
Aengus Tran, Chief Data Scientist at Harrison-AI and co-developer Dr Simon Cooke, Scientific Director at IVFAustralia, of Ivy, has presented the latest data on this system overnight at the American Society of Reproductive Medicine, in Denver. The significance of this work for the future of IVF has been recognised in the conference media release linked here.
Time-lapse videos of thousands of embryos during their development were used to ‘train’ the Ivy AI without the potential for interference from human bias or subjective assessment. The viability of Ivy, AI has been further validated since our preclinical data were originally announced in June 2018.
“Now with growing data and scientific evaluation of the Ivy AI technology system, we are gaining even more confidence of its ability” said A/Prof Illingworth, Medical Director of IVFAustralia. “Ivy has correctly identified with 93% accuracy whether a particular embryo will progress to a fetal heartbeat, using more than 10,000 embryos from 1,603 patients aged between 22 and 50 (7.3 million images have been analysed). This data reaffirms that artificial intelligence is leading the way to be the most dominant embryo selection tool used in human embryology.”
Virtus Health is rolling the Ivy, AI capability out through our network of laboratories in Australia and Europe to enable rapid introduction to patient care in the new year.